Mostrar el registro sencillo del ítem
Menke-Hennekam syndrome; delineation of domain-specific subtypes with distinct clinical and DNA methylation profiles.
dc.rights.license | open | en_US |
dc.contributor.author | HAGHSHENAS, Sadegheh | |
dc.contributor.author | BOUT, Hidde J | |
dc.contributor.author | SCHIJNS, Josephine M | |
dc.contributor.author | LEVY, Michael A | |
dc.contributor.author | KERKHOF, Jennifer | |
dc.contributor.author | BHAI, Pratibha | |
dc.contributor.author | MCCONKEY, Haley | |
dc.contributor.author | JENKINS, Zandra A | |
dc.contributor.author | WILLIAMS, Ella M | |
dc.contributor.author | HALLIDAY, Benjamin J | |
dc.contributor.author | HUISMAN, Sylvia A | |
dc.contributor.author | LAUFFER, Peter | |
dc.contributor.author | DE WAARD, Vivian | |
dc.contributor.author | WITTEVEEN, Laura | |
dc.contributor.author | BANKA, Siddharth | |
dc.contributor.author | BRADY, Angela F | |
dc.contributor.author | GALAZZI, Elena | |
hal.structure.identifier | Service de génétique médicale | |
hal.structure.identifier | Université de Bordeaux [UB] | |
hal.structure.identifier | CHU de Bordeaux Pellegrin [Bordeaux] | |
hal.structure.identifier | Laboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) [U1211 INSERM/MRGM] | |
dc.contributor.author | VAN GILS, Julien | |
dc.contributor.author | HURST, Anna C E | |
dc.contributor.author | KAISER, Frank J | |
hal.structure.identifier | Hôpital Pellegrin | |
hal.structure.identifier | Service de génétique médicale | |
hal.structure.identifier | Université de Bordeaux [UB] | |
hal.structure.identifier | Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux] | |
hal.structure.identifier | Laboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) [U1211 INSERM/MRGM] | |
dc.contributor.author | LACOMBE, Didier | |
dc.contributor.author | MARTINEZ-MONSENY, Antonio F | |
hal.structure.identifier | Hôpital Pellegrin | |
hal.structure.identifier | Service de génétique médicale | |
hal.structure.identifier | Centre Génomique Fonctionnelle Bordeaux [Bordeaux] [CGFB] | |
hal.structure.identifier | Université de Bordeaux [UB] | |
hal.structure.identifier | Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux] | |
hal.structure.identifier | Laboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) [U1211 INSERM/MRGM] | |
dc.contributor.author | FERGELOT, Patricia | |
dc.contributor.author | MONTEIRO, Fabíola P | |
dc.contributor.author | PARENTI, Ilaria | |
dc.contributor.author | PERSANI, Luca | |
dc.contributor.author | SANTOS-SIMARRO, Fernando | |
dc.contributor.author | SIMPSON, Brittany N | |
dc.contributor.author | ALDERS, Mariëlle | |
dc.contributor.author | ROBERTSON, Stephen P | |
dc.contributor.author | SADIKOVIC, Bekim | |
dc.contributor.author | MENKE, Leonie A | |
dc.date.accessioned | 2024-07-16T08:26:53Z | |
dc.date.available | 2024-07-16T08:26:53Z | |
dc.date.issued | 2024-03-29 | |
dc.identifier.issn | 2666-2477 | en_US |
dc.identifier.uri | https://oskar-bordeaux.fr/handle/20.500.12278/200956 | |
dc.description.abstractEn | CREB-binding protein (CBP, encoded by CREBBP) and its paralog E1A-associated protein (p300, encoded by EP300) are involved in histone acetylation and transcriptional regulation. Variants that produce a null allele or disrupt the catalytic domain of either protein cause Rubinstein-Taybi syndrome (RSTS), while pathogenic missense and in-frame indel variants in parts of exons 30 and 31 cause phenotypes recently described as Menke-Hennekam syndrome (MKHK). To distinguish MKHK subtypes and define their characteristics, molecular and extended clinical data on 82 individuals (54 unpublished) with variants affecting CBP (n = 71) or p300 (n = 11) (NP_004371.2 residues 1,705-1,875 and NP_001420.2 residues 1,668-1,833, respectively) were summarized. Additionally, genome-wide DNA methylation profiles were assessed in DNA extracted from whole peripheral blood from 54 individuals. Most variants clustered closely around the zinc-binding residues of two zinc-finger domains (ZZ and TAZ2) and within the first α helix of the fourth intrinsically disordered linker (ID4) of CBP/p300. Domain-specific methylation profiles were discerned for the ZZ domain in CBP/p300 (found in nine out of 10 tested individuals) and TAZ2 domain in CBP (in 14 out of 20), while a domain-specific diagnostic episignature was refined for the ID4 domain in CBP/p300 (in 21 out of 21). Phenotypes including intellectual disability of varying degree and distinct physical features were defined for each of the regions. These findings demonstrate existence of at least three MKHK subtypes, which are domain specific (MKHK-ZZ, MKHK-TAZ2, and MKHK-ID4) rather than gene specific (CREBBP/EP300). DNA methylation episignatures enable stratification of molecular pathophysiologic entities within a gene or across a family of paralogous genes. | |
dc.language.iso | EN | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject.en | CREB-binding protein | |
dc.subject.en | DNA methylation | |
dc.subject.en | E1A-associated protein p300 | |
dc.subject.en | MKHK | |
dc.subject.en | Menke-Hennekam syndrome | |
dc.subject.en | Rubinstein-Taybi syndrome | |
dc.subject.en | Episignatures | |
dc.subject.en | Intellectual disability | |
dc.subject.en | Intrinsically disordered linker | |
dc.subject.en | Zinc-finger domain | |
dc.title.en | Menke-Hennekam syndrome; delineation of domain-specific subtypes with distinct clinical and DNA methylation profiles. | |
dc.title.alternative | HGG Adv | en_US |
dc.type | Article de revue | en_US |
dc.identifier.doi | 10.1016/j.xhgg.2024.100287 | en_US |
dc.subject.hal | Sciences du Vivant [q-bio]/Génétique | en_US |
dc.identifier.pubmed | 38553851 | en_US |
bordeaux.journal | Human Genetics and Genomics Advances | en_US |
bordeaux.page | 100287 | en_US |
bordeaux.volume | 5 | en_US |
bordeaux.hal.laboratories | Maladies Rares : Génétique et Métabolisme (MRGM) - UMR 1211 | en_US |
bordeaux.issue | 3 | en_US |
bordeaux.institution | Université de Bordeaux | en_US |
bordeaux.institution | INSERM | en_US |
bordeaux.peerReviewed | oui | en_US |
bordeaux.inpress | non | en_US |
bordeaux.identifier.funderID | Genome Canada | en_US |
bordeaux.identifier.funderID | Ontario Genomics Institute | en_US |
bordeaux.identifier.funderID | Manchester Biomedical Research Centre | en_US |
bordeaux.identifier.funderID | European Rare Kidney Disease Reference Network | en_US |
bordeaux.import.source | pubmed | |
hal.identifier | hal-04649255 | |
hal.version | 1 | |
hal.date.transferred | 2024-07-16T08:26:59Z | |
hal.popular | non | en_US |
hal.audience | Internationale | en_US |
hal.export | true | |
workflow.import.source | pubmed | |
dc.rights.cc | CC BY | en_US |
bordeaux.COinS | ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Human%20Genetics%20and%20Genomics%20Advances&rft.date=2024-03-29&rft.volume=5&rft.issue=3&rft.spage=100287&rft.epage=100287&rft.eissn=2666-2477&rft.issn=2666-2477&rft.au=HAGHSHENAS,%20Sadegheh&BOUT,%20Hidde%20J&SCHIJNS,%20Josephine%20M&LEVY,%20Michael%20A&KERKHOF,%20Jennifer&rft.genre=article |